Raymond James raised the firm’s price target on Intuitive Surgical (ISRG) to $603 from $592 and keeps an Outperform rating on the shares. Intuitive Surgical’s Q3 results were strong, with material upside across most metrics, including 23% revenue and 30% year over year EPS growth, the analyst tells investors in a research note. Management commentary’s was encouraging, especially around dV5 utilization trends, the firm adds.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical price target raised to $655 from $536 at Baird
- Intuitive Surgical price target raised to $610 from $595 at Piper Sandler
- Intuitive Surgical price target raised to $589 from $529 at BTIG
- Intuitive Surgical’s Strong Financial Performance and Strategic Advancements Drive Buy Rating
- Intuitive Surgical’s Strong Q3 Performance and Strategic Growth Initiatives Justify Buy Rating